Focus: CFM Pharma is a small-molecule pharmaceutical company founded in 2007, headquartered in the Netherlands and focused on ophthalmology and neurology indications. The company appears to be early-stage with limited public pipeline visibility.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
11 added, 12 removed. Backfill posture.
CFM Pharma is a speculative career choice best suited to early-career scientists seeking niche expertise in ophthalmology/neurology small molecules, but limited transparency on pipeline and financials create risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CFM Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from CFM Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles